Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04828824 · ClinicalTrials.gov registry record · Phase 4

Premature Discontinuation of Contraceptive Implants

A Phase 4 study of Contraception Behavior, sponsored by University of Colorado, Denver.

Recruiting
Registry status
Phase 4
Development phase
600
Enrollment target
1
Study location

NCT04828824 is a Phase 4 study of Contraception Behavior that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 600 participants, below the 811-participant average among 11 other Contraception Behavior trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04828824, a Phase 4 study of Contraception Behavior, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
Phase 4
Development phase
600 participants
Enrollment target
1
Study location

Study Summary

To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (COCR intervention) to participants given standard counseling (comparator).

Conditions Studied

Interventions

  • DRUG Ethinyl Estradiol / Norgestimate Oral Tablet

Study Locations (1)

Colorado

  • Children's Hospital Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2021-06-18
Est. Completion 2025-12-31
Phase Phase 4

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT04828824

The ClinicalTrials.gov registry entry for NCT04828824 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 811-participant average among 11 other Contraception Behavior trials with a reported enrollment target (26% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Contraception Behavior appearing as the primary indexed condition, and to 1 intervention - of which Ethinyl Estradiol / Norgestimate Oral Tablet is the first listed.

NCT04828824 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04828824 about?

NCT04828824 is a clinical study titled "Premature Discontinuation of Contraceptive Implants". To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (COCR intervention) to participants given standard counseling (comparator).

What is the current status of trial NCT04828824?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 600 participants. The study started on 2021-06-18. Estimated completion is 2025-12-31.

What conditions does trial NCT04828824 study?

This clinical trial studies the following conditions: Contraception Behavior.

What interventions are being tested in trial NCT04828824?

The interventions under investigation include: Ethinyl Estradiol / Norgestimate Oral Tablet (DRUG).

Who is sponsoring clinical trial NCT04828824?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04828824 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Contraception Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.